Hyperion DeFi, Inc. (HYPD)
NASDAQ: HYPD · Real-Time Price · USD
3.600
+0.030 (0.84%)
At close: May 8, 2026, 4:00 PM EDT
3.530
-0.070 (-1.94%)
After-hours: May 8, 2026, 7:47 PM EDT
Company Description
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States.
It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem.
It also develops the Optejet User Filled Device for horizontal, microdose spray delivery of ophthalmic liquids, such as artificial tears and lens rewetting products, as well as related topical ocular therapies.
The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025.
Hyperion DeFi, Inc. was founded in 2014 and is based in Laguna Hills, California.
Hyperion DeFi, Inc.
| Country | United States |
| Founded | 2014 |
| IPO Date | Jan 25, 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Hyunsu Jung |
Contact Details
Address: 23461 South Point Drive, Suite 390 Laguna Hills, California 92653 United States | |
| Phone | 833 393 6684 |
| Website | hyperiondefi.com |
Stock Details
| Ticker Symbol | HYPD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1682639 |
| CUSIP Number | 30234E104 |
| ISIN Number | US30234E2037 |
| Employer ID | 47-1178401 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hyunsu Jung | Chief Executive Officer, Chief Investment Officer and Director |
| David Knox C.F.A. | Chief Financial Officer and Treasurer |
| Robert Rubenstein | General Counsel and Secretary |
| Jason Assad | Investor Contact |
| Alexander Lobo | Investor Contact |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 6, 2026 | 8-K | Current Report |
| May 6, 2026 | 424B5 | Filing |
| May 5, 2026 | ARS | Filing |
| May 5, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 5, 2026 | DEF 14A | Other definitive proxy statements |
| May 5, 2026 | 424B5 | Filing |
| Apr 17, 2026 | PRE 14A | Other preliminary proxy statements |
| Apr 1, 2026 | SCHEDULE 13G/A | Filing |
| Mar 30, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |